Which is more cost-effective under the MELD system: Primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?

HPB

Volumn 13, Issue 11, 2011, Pages 783-791

  Landman, Matthew P ^a   Feurer, Irene D ^a,b,c   Pinson, C Wright ^a   Moore, Derek E ^a,c  

^a Vanderbilt University Transplant Center   (United States)

^b Department of Biostatistics ^*  (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

hepatocellular carcinoma < liver; outcomes < transplant; radiological intervention CT US guided < liver; resection < liver

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; DECISION TREE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; QUALITY ADJUSTED LIFE YEAR; SIMULATION; STATISTICAL MODEL;

EID: 80054809138     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2011.00355.x     Document Type: Article

References (53)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. (2011) Global cancer statistics. CA Cancer J Clin Feb 2011; doi: 10.3322/caac.20107
2. Altekruse SF, McGlynn KA, Reichman ME,. (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27: 1485-1491.
3. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A,. (1993) Liver resection vs. transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218: 145-151. (Pubitemid 23229140)
4. Ringe B, Pichlmayr R, Wittekind C, Tusch G,. (1991) Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15: 270-285.
5. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al,. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699. (Pubitemid 26079803)
6. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, et al,. (2002) Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 8: 873-883. (Pubitemid 35154015)
7. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al,. (2004) Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 10: 36-41. (Pubitemid 38885890)
8. Ioannou GN, Perkins JD, Carithers RL Jr,. (2008) Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 134: 1342-1351. (Pubitemid 351615357)
9. Lau WY, Lai EC,. (2009) The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 249: 20-25.
10. DuBay DA, Sandroussi C, Kachura JR, Ho CS, Beecroft JR, Vollmer CM, et al,. (2011) Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. HPB (Oxford) 13: 24-32.
11. Schwarz RE, Smith DD,. (2008) Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg 195: 829-836. (Pubitemid 351749460)
12. Birkmeyer JD, Liu JY,. (2003) Decision analysis models: opening the black box. Surgery 133: 1-4. (Pubitemid 36183119)
13. Inadomi JM,. (2004) Decision analysis and economic modelling: a primer. Eur J Gastroenterol Hepatol 16: 535-542. (Pubitemid 38703861)
14. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB,. (1996) Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 276: 1253-1258. (Pubitemid 26337709)
15. Siegel JE, Weinstein MC, Russell LB, Gold MR,. (1996) Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 276: 1339-1341. (Pubitemid 26346934)
16. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al,. (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation vs. percutaneous ethanol injection. Radiology 228: 235-240. (Pubitemid 36736097)
17. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC,. (2005) Randomized controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54: 1151-1156.
18. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al,. (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129: 122-130. (Pubitemid 41002049)
19. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC,. (1996) The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 276: 1172-1177. (Pubitemid 26329746)
20. Weinstein MC, Stason WB,. (1977) Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 296: 716-721. (Pubitemid 8066534)
21. Torrance GW,. (1997) Preferences for health outcomes and cost-utility analysis. Am J Manag Care 3 Suppl.: 8-20.
22. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ,. (1985) Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 5: 157-177. (Pubitemid 16130640)
23. Laupacis A, Feeny D, Detsky AS, Tugwell PX,. (1992) How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 146: 473-481.
24. Freeman RB, Edwards EB, Harper AM,. (2006) Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant 6: 1416-1421. (Pubitemid 44030324)
25. Sarasin FP, Giostra E, Mentha G, Hadengue A,. (1998) Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 28: 436-442. (Pubitemid 28363671)
26. El-Serag HB, Mallat DB, Rabeneck L,. (2005) Management of the single liver nodule in a cirrhotic patient: a decision analysis model. J Clin Gastroenterol 39: 152-159. (Pubitemid 40130030)
27. Sarasin FP, Giostra E, Hadengue A,. (1996) Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis. Am J Med 101: 422-434. (Pubitemid 26392861)
28. Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, et al,. (2007) Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess 11: 1-206.
29. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB,. (2010) Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 52: 132-141.
30. Naugler WE, Sonnenberg A,. (2010) Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma. Liver Transpl 16: 1186-1194.
31. Suriawinata A, Thung SN,. (2010) Molecular signature of early hepatocellular carcinoma. Oncology 78 (Suppl. 1): 36-39.
32. Tsuchiya M, Parker JS, Kono H, Matsuda M, Fujii H, Rusyn I,. (2010) Gene expression in non-tumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma. Mol Cancer 9: 74 doi: 10.1186/1476-4598-9-74
33. Cho YK, Kim JK, Kim WT, Chung JW,. (2010) Hepatic resection vs. radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 51: 1284-1290.
34. Llovet JM, Fuster J, Bruix J,. (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection vs. transplantation. Hepatology 30: 1434-1440.
35. Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E, et al,. (2002) Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut 50: 123-128. (Pubitemid 34028315)
36. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, et al,. (2002) Complications of radiofrequency coagulation of liver tumours. Br J Surg 89: 1206-1222. (Pubitemid 36002536)
37. Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, et al,. (2004) Early and late complications after radiofrequency ablation of malignant liver tumours in 608 patients. Ann Surg 239: 450-458. (Pubitemid 38372760)
38. D'Amico G, Garcia-Tsao G, Pagliaro L,. (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44: 217-231. (Pubitemid 41772537)
39. Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, Shenoy S, et al,. (2006) Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 203: 411-420. (Pubitemid 44416253)
40. Molinari M, Helton S,. (2009) Hepatic resection vs. radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. Am J Surg 198: 396-406.
41. Porrett PM, Peterman H, Rosen M, Sonnad S, Soulen M, Markmann JF, et al,. (2006) Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 12: 665-673.
42. Llovet JM, Schwartz M, Mazzaferro V,. (2005) Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25: 181-200. (Pubitemid 40781071)
43. Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. (2002) Longterm survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235: 373-382. (Pubitemid 34183888)
44. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al,. (2003) Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 238: 508-518.
45. Cucchetti A, Vitale A, Gaudio MD, Ravaioli M, Ercolani G, Cescon M, et al,. (2010) Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant 10: 619-627.
46. Cheng SJ, Freeman RB Jr, Wong JB,. (2002) Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl 8: 323-328. (Pubitemid 34467364)
47. Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT,. (2008) Treatment before liver transplantation for HCC. Ann Surg Oncol 15: 993-1000.
48. Lee KK, Kim DG, Moon IS, Lee MD, Park JH,. (2010) Liver transplantation vs. liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol 101: 47-53.
49. Shimozawa N, Hanazaki K,. (2004) Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 198: 356-365. (Pubitemid 38283726)
50. Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U,. (2005) Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 3: 75-84. (Pubitemid 40092947)
51. Andersson KL, Salomon JA, Goldie SJ, Chung RT,. (2008) Cost-effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 6: 1418-1424.
52. Stein K, Rosenberg W, Wong J,. (2002) Cost-effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut 50: 253-258. (Pubitemid 34087941)
53. Wright M, Grieve R, Roberts J, Main J, Thomas HC,. (2006) Health benefits of antiviral therapy for mild chronic hepatitis C: randomized controlled trial and economic evaluation. Health Technol Assess 10: 1-113.